• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Remission in psoriatic arthritis-where are we now?

    Thumbnail
    View/Open
    Nash434739Accepted.pdf (271.5Kb)
    File version
    Accepted Manuscript (AM)
    Author(s)
    Coates, Laura C
    Conaghan, Philip G
    D'Agostino, Maria Antonietta
    De Wit, Maarten
    FitzGerald, Oliver
    Kvien, Tore K
    Lories, Rik
    Mease, Philip
    Nash, Peter
    Schett, Georg
    Soriano, Enrique R
    Emery, Paul
    Griffith University Author(s)
    Nash, Peter
    Year published
    2018
    Metadata
    Show full item record
    Abstract
    Advances in treatments and treatment strategies for PsA have led to many patients responding well to management of their disease, and targeting remission as a treatment goal is now a possibility. Treat to target is a strategy aimed at maximizing benefit, irrespective of the type of medication used, by monitoring disease activity and using it to guide therapy. The measurement of response to treatment has been the subject of wide discussions among experts for some time, and many instruments exist. Comparisons of the different measures and their different strengths and weaknesses is ongoing. The impact of modern imaging techniques ...
    View more >
    Advances in treatments and treatment strategies for PsA have led to many patients responding well to management of their disease, and targeting remission as a treatment goal is now a possibility. Treat to target is a strategy aimed at maximizing benefit, irrespective of the type of medication used, by monitoring disease activity and using it to guide therapy. The measurement of response to treatment has been the subject of wide discussions among experts for some time, and many instruments exist. Comparisons of the different measures and their different strengths and weaknesses is ongoing. The impact of modern imaging techniques on monitoring disease progression is also evolving, and advanced techniques using both MRI and US have the potential to improve management of PsA through identification of risk factors for poor prognosis as well as accurate assessment of inflammation and damage, including subclinical disease. Increased understanding of the pathways that drive the pathogenesis of PsA will be key to identifying specific biomarkers for the disease and developing effective treatment strategies. Targets for response, considerations for use of a treat to target strategy in PsA, different imaging techniques and serological aspects of remission are all discussed in this review, and areas for further research are identified.
    View less >
    Journal Title
    Rheumatology
    Volume
    57
    Issue
    8
    DOI
    https://doi.org/10.1093/rheumatology/kex344
    Copyright Statement
    © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Rheumatology following peer review. The definitive publisher-authenticated version Remission in psoriatic arthritis—where are we now?, Rheumatology, Volume 57, Issue 8, August 2018 is available online at: 10.1093/rheumatology/kex344
    Subject
    Clinical sciences
    Immunology
    Health services and systems
    Public health
    Science & Technology
    Life Sciences & Biomedicine
    Rheumatology
    PsA
    remission
    Publication URI
    http://hdl.handle.net/10072/395968
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander